Mechanism of heterochromatin regulation by STAT
Mechanism of heterochromatin regulation by STAT
批准号:
10245005
负责人:
WILLIS X LI
金额:
$31.6万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-20 至 2023-08-31
关键词:
AffinityAllelesAmino AcidsAnimalsAntibodiesBindingBiological ProcessCell Cycle StageCell NucleusCell physiologyCellsChromatinComplexDNADNA BindingDNA SequenceDNA-Binding ProteinsDrosophila genusElementsEpigenetic ProcessEuchromatinEventFeedbackGene SilencingGenesGeneticGenetic ResearchGenetic TranscriptionGenome StabilityGenomicsGoalsHeterochromatinHistonesHumanLightLongevityMaintenanceMolecularMolecular ConformationPathway interactionsPhosphorylationPhysiologicalPlayPropertyProteinsRNA BindingRegulationReportingRoleSiteTemperatureTestingTumor SuppressionTyrosineUntranslated RNAbiochemical toolschromatin immunoprecipitationdeep sequencingdimerexperimental studygene repressiongenome integrityheterochromatin-specific nonhistone chromosomal protein HP-1human diseasemutantrecruittumor growthwhole genome
中文摘要
STAT调控异染色质的机制
英文摘要
Mechanism of heterochromatin regulation by STAT
Heterochromatin is a tightly packed form of DNA important for chromosomal compaction and transcriptional
silencing as well as for genome stability, animal longevity, and tumor suppression. How heterochromatin
dynamics, i.e., its establishment, maintenance, and loss, is controlled remains incompletely understood. We
have previously demonstrated a physiological role of uSTAT in heterochromatin maintenance, but the
mechanism remains unclear. The overall goal of this project is to investigate, at the molecular level, the role of
STAT in establishing and maintaining heterochromatin, and to understand how STAT phosphorylation can
serve as a molecular switch converting gene silencing to active transcription. We have previously shown by
immunostaining that a fraction of STAT not phosphorylated at the critical tyrosine around amino acid 700
(termed uSTAT) is localized in the nucleus in association with Heterochromatin Protein 1 (HP1). We have
shown genetically that STAT is essential for heterochromatin maintenance, and that STAT activation (by
phosphorylation on this tyrosine) is associated with heterochromatin disruption. We have further shown that
human uSTAT5A is capable of promoting heterochromatin formation and suppressing tumor growth. In new
preliminary studies using chromatin immunoprecipitation followed by deep sequencing (ChIP-seq), we have
found that the majority of chromatin-bound Drosophila STAT is localized in heterochromatin, and that loss of
STAT leads to a global decrease in heterochromatin, which is marked by trimethylated histone 3 at lys9
(H3K9me3). We have further found that, when forced to bind to euchromatin, uSTAT can repress nearby
genes in an HP1-dependent manner. These results suggest that uSTAT may play an important role not only in
maintaining but also in initiating heterochromatin formation. HP1 and H3K9me3 are hallmarks of
heterochromatin, with HP1 being the central component. It has been shown that recruiting HP1 to euchromatin
is sufficient for heterochromatin formation. However, HP1 does not bind DNA directly and has only weak
affinity for H3K9me3, and thus may require DNA-binding protein factors for its initial recruitment to
heterochromatic loci, or for strengthening its binding to H3K9me3. We hypothesize that uSTAT plays roles in
both establishment and maintenance of heterochromatin due to the molecular confirmation of uSTAT dimers.
We will use a combination of genomic, genetic, and biochemical tools to investigate the initial events leading to
heterochromatin establishment, the respective roles of STAT and HP1 in heterochromatin maintenance, the
requirement for cis-element in uSTAT binding and HP1 recruitment, and the properties of uSTAT and pSTAT
dimers in DNA and HP1 binding. Understanding the molecular mechanism of noncanonical STAT function in
heterochromatin regulation should shed light on not only the basic cell biological process of heterochromatin
dynamics but also heterochromatic gene silencing relevant to tumor suppression and epigenetic human
diseases.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
A Screening Method for Identification of Heterochromatin-Promoting Drugs Using Drosophila.
使用果蝇鉴定异染色质促进药物的筛选方法。
DOI:
10.3791/60917
发表时间:
2020
期刊:
Journal of visualized experiments : JoVE
影响因子:
--
作者:
[Zhang,Lin, Dao,Kenny, Kang,Angela, Loyola,AndreC, Shang,Robin, Li,Jinghong, Li,WillisX]
通讯作者:
Li,WillisX
Computational simulation of JAK/STAT signaling in somatic versus germline stem cells.
体细胞与生殖干细胞中 JAK/STAT 信号传导的计算模拟。
DOI:
10.1002/dvdy.684
发表时间:
2023
期刊:
Developmental dynamics : an official publication of the American Association of Anatomists
影响因子:
--
作者:
[Li,WillisX]
通讯作者:
Li,WillisX
DOI:
10.1007/s15010-020-01566-6
发表时间:
2021-06
期刊:
Infection
影响因子:
7.5
作者:
[Li WX]
通讯作者:
Li WX
DOI:
10.1042/bsr20230612
发表时间:
2023-08-31
期刊:
BIOSCIENCE REPORTS
影响因子:
4
作者:
[Maninang, Christine, Li, Jinghong, Li, Willis X.]
通讯作者:
Li, Willis X.
Identification of methotrexate as a heterochromatin-promoting drug.
鉴定甲氨蝶呤作为异染色质促进药物。
DOI:
10.1038/s41598-019-48137-w
发表时间:
2019
期刊:
Scientific reports
影响因子:
4.6
作者:
[Loyola,AndreC, Zhang,Lin, Shang,Robin, Dutta,Pranabananda, Li,Jinghong, Li,WillisX]
通讯作者:
Li,WillisX
共 7 条
Functions of a novel suppressor of oncogenic Ras
-
批准号:10579551
-
项目类别:
-
资助金额:$7.9万
-
财政年份:2023
-
负责人:WILLIS X LI
-
依托单位:
Mechanism of heterochromatin regulation by STAT
-
批准号:9643400
-
项目类别:
-
资助金额:$31.42万
-
财政年份:2018
-
负责人:WILLIS X LI
-
依托单位:
Mechanism of heterochromatin regulation by STAT
-
批准号:9788099
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2018
-
负责人:WILLIS X LI
-
依托单位:
Request for a Zeiss LSM 710 Confocal Microscope
-
批准号:7792856
-
项目类别:
-
资助金额:$42.82万
-
财政年份:2010
-
负责人:WILLIS X LI
-
依托单位:
Epigenetic tumor induction by heterochromatin instability
-
批准号:7826613
-
项目类别:
-
资助金额:$31.75万
-
财政年份:2009
-
负责人:WILLIS X LI
-
依托单位:
Epigenetic tumor induction by heterochromatin instability
-
批准号:8193217
-
项目类别:
-
资助金额:$31.69万
-
财政年份:2009
-
负责人:WILLIS X LI
-
依托单位:
Epigenetic tumor induction by heterochromatin instability
-
批准号:8401109
-
项目类别:
-
资助金额:$29.86万
-
财政年份:2009
-
负责人:WILLIS X LI
-
依托单位:
Epigenetic tumor induction by heterochromatin instability
-
批准号:7653397
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2009
-
负责人:WILLIS X LI
-
依托单位:
Network Interaction between EGFR and TGFbeta Pathways
-
批准号:7339884
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2006
-
负责人:WILLIS X LI
-
依托单位:
Network Interaction between EGFR and TGFbeta Pathways
-
批准号:7032753
-
项目类别:
-
资助金额:$24.02万
-
财政年份:2006
-
负责人:WILLIS X LI
-
依托单位:
Network Interaction between EGFR and TGFbeta Pathways
-
批准号:7168215
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2006
-
负责人:WILLIS X LI
-
依托单位:
Network Interaction between EGFR and TGFbeta Pathways
-
批准号:7571662
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2006
-
负责人:WILLIS X LI
-
依托单位:
Genetic Analysis of Intracellular Signaling Crosstalk
-
批准号:6620902
-
项目类别:
-
资助金额:$26.46万
-
财政年份:2002
-
负责人:WILLIS X LI
-
依托单位:
Genetic Analysis of Intracellular Signaling Crosstalk
-
批准号:6852646
-
项目类别:
-
资助金额:$26.46万
-
财政年份:2002
-
负责人:WILLIS X LI
-
依托单位:
Genetic Analysis of Intracellular Signaling Crosstalk
-
批准号:7016382
-
项目类别:
-
资助金额:$25.84万
-
财政年份:2002
-
负责人:WILLIS X LI
-
依托单位:
Genetic Analysis of Intracellular Signaling Crosstalk
-
批准号:6721220
-
项目类别:
-
资助金额:$26.46万
-
财政年份:2002
-
负责人:WILLIS X LI
-
依托单位:
Genetic Analysis of Intracellular Signaling Crosstalk
-
批准号:6422939
-
项目类别:
-
资助金额:$26.54万
-
财政年份:2002
-
负责人:WILLIS X LI
-
依托单位:
海外基金